Aaron Rodgers seemingly wants to be a Viking, but do they want him? He is waiting to find out at the very least.

Viking’s fourth-quarter results back up the sentiment that demand for its cruises is holding up.

Viking Therapeutics Inc.’s stock soared 8% Wednesday, after the maker of a promising weight-loss pill secured a manufacturing ...

Over the past few days, as the rest of the stock market melted down, a revolution has been quietly brewing in the market for ...

Viking Holdings (NYSE:VIK) reports robust Q4 growth with a 20.5% sales surge and plans to expand in 2025. Discover key ...

Greenland is having a moment in the international spotlight. U.S. President Donald Trump has been maneuvering to gain control ...

An exhibition delving into the legacy of the Vikings on the Isle of Man has opened. The display at Rushen Heritage Centre ...

Key Takeaways Viking Holdings shares dropped Tuesday as executives warned of macroeconomic "uncertainties" on the cruise ...

Viking Therapeutics eyes billion-dollar obesity drug markets with pivotal trials and major production deals. Read more about ...

In the closing of the recent trading day, Viking Therapeutics, Inc. (VKTX) stood at $29.73, denoting a +0.61% change from the preceding trading day.

Viking launches its 108-page 2025-2027 World Voyages Collection brochure featuring a range of extended travel itineraries.

Archaeologists from the Stockholm Shipwreck Museum hope to secure funding for further research and excavation of the ...